Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06836284Not ApplicableRecruiting

The Evira Study: Additional Support During Obesity Treatment

Role: collaborator

NCT06807489Completed

Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool

Role: collaborator

NCT04917601Not ApplicableRecruiting

A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

Role: collaborator

NCT06665893Not ApplicableCompleted

Local Proof of Concept of Evira in Abu Dhabi Study

Role: collaborator

All 4 trials loaded